160 related articles for article (PubMed ID: 37610509)
1. Immune changes induced by periampullary adenocarcinoma are reversed after tumor resection and modulate the postoperative survival.
Landerer A; Himmelsbach R; Biesel EA; Fichtner-Feigl S; Wittel UA; Chikhladze S
Discov Oncol; 2023 Aug; 14(1):153. PubMed ID: 37610509
[TBL] [Abstract][Full Text] [Related]
2. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.
Schwarz RE; Keny H
Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994
[TBL] [Abstract][Full Text] [Related]
3. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death.
van der Gaag NA; Harmsen K; Eshuis WJ; Busch ORC; van Gulik TM; Gouma DJ
Eur J Surg Oncol; 2014 May; 40(5):551-558. PubMed ID: 24388408
[TBL] [Abstract][Full Text] [Related]
4. Immunological effects of hybrid minimally invasive versus conventional open pancreatoduodenectomy - A single center cohort study.
Himmelsbach R; Landerer A; Hipp J; Hopt UT; Fichtner-Feigl S; Wittel UA; Ruess DA
Pancreatology; 2021 Aug; 21(5):965-974. PubMed ID: 33832820
[TBL] [Abstract][Full Text] [Related]
5. Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial.
Jin J; Shi Y; Chen M; Qian J; Qin K; Wang Z; Chen W; Jin W; Lu F; Li Z; Wu Z; Jian L; Han B; Liang X; Sun C; Wu Z; Mou Y; Yin X; Huang H; Chen H; Gemenetzis G; Deng X; Peng C; Shen B
Trials; 2021 Dec; 22(1):954. PubMed ID: 34961558
[TBL] [Abstract][Full Text] [Related]
6. Monitoring Pre- and Post-Operative Immune Alterations in Patients With Locoregional Colorectal Cancer Who Underwent Laparoscopy by Single-Cell Mass Cytometry.
Zhou C; Wang Z; Jiang B; Di J; Su X
Front Immunol; 2022; 13():807539. PubMed ID: 35185893
[TBL] [Abstract][Full Text] [Related]
7. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
8. Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome.
Sohn TA; Lillemoe KD; Cameron JL; Pitt HA; Huang JJ; Hruban RH; Yeo CJ
Ann Surg; 1999 Mar; 229(3):393-400. PubMed ID: 10077052
[TBL] [Abstract][Full Text] [Related]
9. Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: A multicentre retrospective cohort study.
van Roessel S; Soer EC; Daamen LA; van Dalen D; Fariña Sarasqueta A; Stommel MWJ; Molenaar IQ; van Santvoort HC; van de Vlasakker VCJ; de Hingh IHJT; Groen JV; Mieog JSD; van Dam JL; van Eijck CHJ; van Tienhoven G; Klümpen HJ; Wilmink JW; Busch OR; Brosens LAA; Groot Koerkamp B; Verheij J; Besselink MG;
Eur J Surg Oncol; 2021 Oct; 47(10):2525-2532. PubMed ID: 33745791
[TBL] [Abstract][Full Text] [Related]
10. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
11. The immunologic consequences of laparoscopy in oncology.
Carter JJ; Whelan RL
Surg Oncol Clin N Am; 2001 Jul; 10(3):655-77. PubMed ID: 11685934
[TBL] [Abstract][Full Text] [Related]
12. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
Byrling J; Ghazi S; Andersson B
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
14. [Surgery for periampullary pancreatic cancer].
Hank T; Klaiber U; Sahora K; Schindl M; Strobel O
Chirurg; 2021 Sep; 92(9):776-787. PubMed ID: 34259884
[TBL] [Abstract][Full Text] [Related]
15. Serum N-Glycome Characterization in Patients with Resectable Periampullary Adenocarcinoma.
Hamfjord J; Saldova R; Stöckmann H; Sandhu V; Bowitz Lothe IM; Buanes T; Lingjærde OC; Labori KJ; Rudd PM; Kure EH
J Proteome Res; 2015 Dec; 14(12):5144-56. PubMed ID: 26515733
[TBL] [Abstract][Full Text] [Related]
16. Perioperative sargramostim (recombinant human GM-CSF) induces an increase in the level of soluble VEGFR1 in colon cancer patients undergoing minimally invasive surgery.
Kirman I; Belizon A; Balik E; Feingold D; Arnell T; Horst P; Kumara S; Cekic V; Jain S; Nasar A; Whelan RL
Eur J Surg Oncol; 2007 Dec; 33(10):1169-76. PubMed ID: 17512160
[TBL] [Abstract][Full Text] [Related]
17. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive colorectal resection for benign pathology is associated with persistent proangiogenic plasma compositional changes.
Shantha Kumara HM; Myers EA; Herath SA; Njoh L; Yan X; Kirchoff D; Dujovny N; Whelan RL
Dis Colon Rectum; 2014 Jun; 57(6):740-6. PubMed ID: 24807599
[TBL] [Abstract][Full Text] [Related]
20. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
